{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:43:43Z","timestamp":1751085823011,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00701-022-05109-w","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T10:03:26Z","timestamp":1642154606000},"page":"737-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor"],"prefix":"10.1007","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-8147","authenticated-orcid":false,"given":"Flavie","family":"Grenier-Chartrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Barrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Lucie","family":"Racu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Luce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Spitaels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Sadeghi-Meibodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"De Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"issue":"4","key":"5109_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1530\/EC-20-0621","volume":"10","author":"L Das","year":"2021","unstructured":"Das L, Vaiphei K, Rai A et al (2021) Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence. Endocr Connect 10(4):387\u2013400. https:\/\/doi.org\/10.1530\/EC-20-0621","journal-title":"Endocr Connect"},{"key":"5109_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106059","volume":"196","author":"FM Dawoud","year":"2020","unstructured":"Dawoud FM, Naylor RM, Giannini C, Swanson AA, Meyer FB, Uhm JH (2020) TTF-1 positive posterior pituitary tumor: limitations of current treatment and potential new hope in BRAF V600E mutation variants. Clin Neurol Neurosurg 196:106059. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106059","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"5109_CR3","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/cancers11121950","volume":"11","author":"A Greco","year":"2019","unstructured":"Greco A, Safi D, Swami U, Ginader T, Milhem M, Zakharia Y (2019) Efficacy and adverse events in metastatic melanoma patients treated with combination BRAF plus MEK inhibitors versus BRAF inhibitors: a systematic review. Cancers 11(12):1950. https:\/\/doi.org\/10.3390\/cancers11121950","journal-title":"Cancers"},{"key":"5109_CR4","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/j.wneu.2021.02.051","volume":"149","author":"H Hasegawa","year":"2021","unstructured":"Hasegawa H, Van Gompel JJ, Oushy SH et al (2021) A comprehensive study of spindle cell oncocytoma of the pituitary gland: series of 6 cases and meta-analysis of 85 cases. World Neurosurg 149:e197\u2013e216. https:\/\/doi.org\/10.1016\/j.wneu.2021.02.051","journal-title":"World Neurosurgery"},{"issue":"4","key":"5109_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535. https:\/\/doi.org\/10.1007\/s00401-017-1769-8","journal-title":"Acta Neuropathol"},{"issue":"141","key":"5109_CR6","first-page":"51","volume":"26","author":"S Maraka","year":"2018","unstructured":"Maraka S, Janku F (2018) BRAF alterations in primary brain tumors. Discov Med 26(141):51\u201360","journal-title":"Discov Med"},{"issue":"3","key":"5109_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/PAS.0b013e31829723e7","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243. https:\/\/doi.org\/10.1097\/PAS.0b013e31829723e7","journal-title":"Endocr Pathol"},{"issue":"11","key":"5109_CR8","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s12022-017-9498-z","volume":"37","author":"O Mete","year":"2013","unstructured":"Mete O, Lopes MB, Asa SL (2013) Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 37(11):1694\u20131699. https:\/\/doi.org\/10.1007\/s12022-017-9498-z","journal-title":"Am J Surg Pathol"},{"key":"5109_CR9","doi-asserted-by":"publisher","unstructured":"Miller MB, Bi WL, Ramkissoon LA, et al (2016) MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma. Oncotarget 7(24):37054\u201337063. https:\/\/doi.org\/10.18632\/oncotarget.9244","DOI":"10.18632\/oncotarget.9244"},{"issue":"5","key":"5109_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40257-014-0088-2","volume":"15","author":"L Peuvrel","year":"2014","unstructured":"Peuvrel L, Dr\u00e9no B (2014) Dermatological toxicity associated with targeted therapies in cancer: optimal management. Am J Clin Dermatol 15(5):425\u2013444. https:\/\/doi.org\/10.1007\/s40257-014-0088-2","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"5109_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/nan.12622","volume":"46","author":"F Roncaroli","year":"2020","unstructured":"Roncaroli F, Chatterjee D, Giannini C et al (2020) Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions. Neuropathol Appl Neurobiol 46(5):493\u2013505. https:\/\/doi.org\/10.1111\/nan.12622","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"5109_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s40618-018-0923-z","volume":"42","author":"FJ Salge-Arrieta","year":"2019","unstructured":"Salge-Arrieta FJ, Carrasco-Moro R, Rodr\u00edguez-Berrocal V, Pian H, Mart\u00ednez-San Mill\u00e1n JS, Iglesias P, Ley-Urz\u00e1iz L (2019) Clinical features, diagnosis and therapy of pituicytoma: an update. J Endocrinol Invest 42(4):371\u2013384. https:\/\/doi.org\/10.1007\/s40618-018-0923-z","journal-title":"J Endocrinol Invest"},{"key":"5109_CR13","doi-asserted-by":"publisher","unstructured":"Sollfrank L, Lettmaier S, Erdmann M, Uslu U (2019) Panniculitis under successful targeted inhibition of the MAPK\/ERK signaling pathway in a patient with BRAF V600E-mutated spindle cell oncocytoma of the pituitary gland. Anticancer Res 39(7):3955\u20133959. https:\/\/doi.org\/10.21873\/anticanres.13549","DOI":"10.21873\/anticanres.13549"},{"issue":"1","key":"5109_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40478-019-0722-6","volume":"7","author":"AN Viaene","year":"2019","unstructured":"Viaene AN, Lee EB, Rosenbaum JN, Nasrallah IM, Nasrallah MP (2019) Histologic, immunohistochemical, and molecular features of pituicytomas and atypical pituicytomas. Acta Neuropathol Commun 7(1):69. https:\/\/doi.org\/10.1186\/s40478-019-0722-6","journal-title":"Acta Neuropathol Commun"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-022-05109-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-022-05109-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-022-05109-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T03:06:54Z","timestamp":1646968014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-022-05109-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5109"],"URL":"https:\/\/doi.org\/10.1007\/s00701-022-05109-w","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"type":"print","value":"0001-6268"},{"type":"electronic","value":"0942-0940"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient has consented to the submission of the case report to the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}